Puberty blockers: Indefinite ban to be introduced


The UK Health Secretary, Wes Streeting, has announced that the ban on giving puberty blockers to under-18s questioning their gender identity is to be made permanent, following a consultation and advice from the Commission on Human Medicines. This comes following a temporary ban that was introduced earlier this year in May. Streeting has criticized the way the drugs were used, calling it a “scandal” and an “unacceptable safety risk” for children diagnosed with gender dysphoria.

Both campaigners in support of the ban and those against it have reacted to the news. Those in support of the ban have commended Streeting for his “integrity”, while those against it have called it discrimination. Puberty blockers are drugs used to delay or prevent the onset of puberty. They were introduced as a way to treat gender dysphoria, however there has been a lack of evidence around their treatment for under-18s.

Streeting’s announcement has not affected the ongoing clinical trial by NHS England which is studying the use of puberty blockers. The results of this study will be reviewed within the context of the evidence that emerges. The indefinite ban on the use of puberty blockers will also be reviewed in 2027 when any new evidence is taken into account.

The discussion around the use of puberty blockers for treating under-18s with gender dysphoria has been high-profile and controversial. The decision to ban the drugs follows publication of a landmark review earlier this year which highlighted the lack of evidence for treating under-18s with puberty-blocking drugs.

While some campaigners for Trans rights have criticized the move, those who have campaigned for a ban on the use of puberty blockers have welcomed it, describing it as another step towards relegating puberty blockers to a shameful chapter in medical history. Despite the ongoing debate, under-18s who were on the drugs before the ban was introduced are still allowed to use them

Read the full article from The BBC here: Read More